Global Rofecoxib Professional Survey Report 2024, Forecast to 2029
Rofecoxib was a COX-2 selective nonsteroidal anti-inflammatory drug (NSAID). It was marketed by Merck & Co. to treat osteoarthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, acute pain conditions, migraine, and dysmenorrhea.
Our market research covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2029 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets.
We can meet the customized needs of customers in multiple dimensions, in-depth and high quality, help customers accurately grasp market opportunities, easily deal with market challenges, properly formulate market strategies, and act quickly to win sufficient market competition time and space for customers.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
The global economy and markets have been remarkably resilient in the face of tightening financial conditions and geopolitical upheaval over the past few years, with economic growth holding up better than most analysts’ expectations.
The global environment has still not settled onto a clear pathway toward a new stability as we enter 2024. In this disjointed world, we confront risks posed by potential volatility across the economic and political spheres. We also see potential opportunities arising from the new reality of greatly segmented global relationships.
We have identified five overlapping themes that will drive global political and economic relationships in 2024: geopolitical reordering, economic fault lines, resource security, supply chain resilience and logistics rewired.
The report will conduct a comprehensive and professional analysis of the Rofecoxib market in 2024 based on the current situation, global economic impact and other aspects.
Market Segment by Product Type
Oral Suspension.
Tablet-Form
Market Segment by Product Application
Osteoarthritis
Rheumatoid Arthritis
Juvenile Rheumatoid Arthritis
Acute Pain Conditions
Migraine
Dysmenorrhea
Finally, the report provides detailed profile and data information analysis of leading company.
Merck
Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Chengdu Meinkai Chemical Co. LTD
Wuhan Xinxin Jiali Biotechnology Co. LTD
Tremeau
Pfizer
Insights and Tools:
This report provides industry-standard analytical accuracy and high data completeness to uncover key opportunities available in the global industry market. Buyers of the report can obtain verified and reliable market forecasts, including revenue forecasts for the overall size of the global industry market.
The report is an effective tool for players to gain a competitive advantage over their competitors and ensure lasting success in the industry market. All findings, data, and information presented in the report have been verified and re-verified with the help of reliable sources. The analysts who authored the report have taken a unique approach to industry-best research and analysis for an in-depth study of the global industry market.
Use both primary and secondary data sources when compiling reports. Primary sources include extensive interviews with key opinion leaders and industry experts such as experienced front-line employees, directors, CEOs and marketing executives, downstream distributors as well as end users. Secondary sources include research on top companies' annual and financial reports, public documents, new journals, and more. We also work with some third-party databases.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
1.To define, describe and forecast the Rofecoxib market by type, application, end user and region
2.Provide enterprise external environment analysis and SWOT analysis
3.Focuses on the key global Rofecoxib manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, and development plans in next few years.
4.Provide market entry strategy analysis for new players or players preparing to enter the market
5.Keep up with international market trends and analyze the impact of the important international events on major global regions
6.Analyze market opportunities for stakeholders to provide market leaders with detailed information on the competitive landscape
Global Rofecoxib Professional Survey Report Report 2024, Forecast to 2029
1 Market Study Overview
1.1 Study Objectives
1.2 Rofecoxib Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research Methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Rofecoxib Segment by Type
2.1.1 Oral Suspension.
2.1.2 Tablet-Form
2.2 Market Analysis by Application
2.2.1 Osteoarthritis
2.2.2 Rheumatoid Arthritis
2.2.3 Juvenile Rheumatoid Arthritis
2.2.4 Acute Pain Conditions
2.2.5 Migraine
2.2.6 Dysmenorrhea
2.3 Global Rofecoxib Market Comparison by Regions (2019-2029)
2.3.1 Global Rofecoxib Market Size (2019-2029)
2.3.2 North America Rofecoxib Status and Prospect (2019-2029)
2.3.3 Europe Rofecoxib Status and Prospect (2019-2029)
2.3.4 Asia-pacific Rofecoxib Status and Prospect (2019-2029)
2.3.5 South America Rofecoxib Status and Prospect (2019-2029)
2.3.6 Middle East & Africa Rofecoxib Status and Prospect (2019-2029)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Rofecoxib Industry Impact
2.5.1 Rofecoxib Business Impact Assessment - Covid-19
2.5.2 Market Trends and Rofecoxib Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Rofecoxib Sales and Market Share by Manufacturer (2019-2024)
3.2 Global Rofecoxib Revenue and Market Share by Manufacturer (2019-2024)
3.3 Global Rofecoxib Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Rofecoxib Manufacturer Market Share
3.5 Top 10 Rofecoxib Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Rofecoxib Market
3.7 Key Manufacturers Rofecoxib Product Offered
3.8 Mergers & Acquisitions Planning
4 Analysis of Rofecoxib Industry Key Manufacturers
4.1 Merck
4.1.1 Company Details
4.1.2 Merck Rofecoxib Product Introduction, Application and Specification
4.1.3 Merck Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.1.4 Main Business Overview
4.1.5 Merck News
4.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
4.2.1 Company Details
4.2.2 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Product Introduction, Application and Specification
4.2.3 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.2.4 Main Business Overview
4.2.5 Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD News
4.3 Chengdu Meinkai Chemical Co. LTD
4.3.1 Company Details
4.3.2 Chengdu Meinkai Chemical Co. LTD Rofecoxib Product Introduction, Application and Specification
4.3.3 Chengdu Meinkai Chemical Co. LTD Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.3.4 Main Business Overview
4.3.5 Chengdu Meinkai Chemical Co. LTD News
4.4 Wuhan Xinxin Jiali Biotechnology Co. LTD
4.4.1 Company Details
4.4.2 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Product Introduction, Application and Specification
4.4.3 Wuhan Xinxin Jiali Biotechnology Co. LTD Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.4.4 Main Business Overview
4.4.5 Wuhan Xinxin Jiali Biotechnology Co. LTD News
4.5 Tremeau
4.5.1 Company Details
4.5.2 Tremeau Rofecoxib Product Introduction, Application and Specification
4.5.3 Tremeau Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.5.4 Main Business Overview
4.5.5 Tremeau News
4.6 Pfizer
4.6.1 Company Details
4.6.2 Pfizer Rofecoxib Product Introduction, Application and Specification
4.6.3 Pfizer Rofecoxib Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.6.4 Main Business Overview
4.6.5 Pfizer News
5 Global Rofecoxib Sales Categorized by Regions
5.1 Global Rofecoxib Revenue, Sales and Market Share by Regions
5.1.1 Global Rofecoxib Sales and Market Share by Regions (2019-2024)
5.1.2 Global Rofecoxib Revenue and Market Share by Regions (2019-2024)
5.2 North America Rofecoxib Sales and Growth Rate (2019-2024)
5.3 Europe Rofecoxib Sales and Growth Rate (2019-2024)
5.4 Asia-pacific Rofecoxib Sales and Growth Rate (2019-2024)
5.5 South America Rofecoxib Sales and Growth Rate (2019-2024)
5.6 Middle East & Africa Rofecoxib Sales and Growth Rate (2019-2024)
6 North America Rofecoxib Market Size Categorized by Countries
6.1 North America Rofecoxib Sales, Revenue and Market Share by Countries
6.1.1 North America Rofecoxib Sales (Volume) by Countries (2019-2024)
6.1.2 North America Rofecoxib Revenue by Countries (2019-2024)
6.1.3 United States Rofecoxib Sales and Growth Rate (2019-2024)
6.1.4 Canada Rofecoxib Sales and Growth Rate (2019-2024)
6.1.5 Mexico Rofecoxib Sales and Growth Rate (2019-2024)
6.2 North America Rofecoxib Revenue (Value) by Manufacturers
6.3 North America Rofecoxib Sales and Market Share by Type (2019-2024)
6.4 North America Rofecoxib Sales Market Share by Application (2019-2024)
7 Europe Rofecoxib Market Size Categorized by Countries
7.1 Europe Rofecoxib Sales, Revenue and Market Share by Countries
7.1.1 Europe Rofecoxib Sales (Volume) by Countries (2019-2024)
7.1.2 Europe Rofecoxib Revenue by Countries (2019-2024)
7.1.3 Germany Rofecoxib Sales and Growth Rate (2019-2024)
7.1.4 UK Rofecoxib Sales and Growth Rate (2019-2024)
7.1.5 France Rofecoxib Sales and Growth Rate (2019-2024)
7.1.6 Russia Rofecoxib Sales and Growth Rate (2019-2024)
7.1.7 Italy Rofecoxib Sales and Growth Rate (2019-2024)
7.1.8 Spain Rofecoxib Sales and Growth Rate (2019-2024)
7.2 Europe Rofecoxib Revenue (Value) by Manufacturers
7.3 Europe Rofecoxib Sales and Market Share by Type (2019-2024)
7.4 Europe Rofecoxib Sales Market Share by Application (2019-2024)
8 Asia-Pacific Rofecoxib Market Size Categorized by Countries
8.1 Asia-pacific Rofecoxib Sales, Revenue and Market Share by Countries
8.1.1 Asia-pacific Rofecoxib Sales (Volume) by Countries (2019-2024)
8.1.2 Asia-pacific Rofecoxib Revenue by Countries (2019-2024)
8.1.3 China Rofecoxib Sales and Growth Rate (2019-2024)
8.1.4 South Korea Rofecoxib Sales and Growth Rate (2019-2024)
8.1.5 Japan Rofecoxib Sales and Growth Rate (2019-2024)
8.1.6 Australia Rofecoxib Sales and Growth Rate (2019-2024)
8.1.7 India Rofecoxib Sales and Growth Rate (2019-2024)
8.1.8 Southeast Asia Rofecoxib Sales and Growth Rate (2019-2024)
8.2 Asia-pacific Rofecoxib Revenue (Value) by Manufacturers
8.3 Asia-pacific Rofecoxib Sales and Market Share by Type (2019-2024)
8.4 Asia-pacific Rofecoxib Sales Market Share by Application (2019-2024)
9 South America Rofecoxib Market Size Categorized by Countries
9.1 South America Rofecoxib Sales, Revenue and Market Share by Countries
9.1.1 South America Rofecoxib Sales (Volume) by Countries (2019-2024)
9.1.2 South America Rofecoxib Revenue by Countries (2019-2024)
9.1.3 Brazil Rofecoxib Sales and Growth Rate (2019-2024)
9.2 South America Rofecoxib Sales and Market Share by Type (2019-2024)
9.3 South America Rofecoxib Sales Market Share by Application (2019-2024)
10 Middle East and Africa Rofecoxib Market Size Categorized by Countries
10.1 Middle East and Africa Rofecoxib Sales, Revenue and Market Share by Countries
10.1.1 Middle East and Africa Rofecoxib Sales (Volume) by Countries (2019-2024)
10.1.2 Middle East and Africa Rofecoxib Revenue by Countries (2019-2024)
10.1.3 GCC Countries Rofecoxib Sales and Growth Rate (2019-2024)
10.1.4 Turkey Rofecoxib Sales and Growth Rate (2019-2024)
10.1.5 Egypt Rofecoxib Sales and Growth Rate (2019-2024)
10.1.6 South America Rofecoxib Sales and Growth Rate (2019-2024)
10.2 Middle East and Africa Rofecoxib Sales and Market Share by Type
10.3 Middle East and Africa Rofecoxib Sales Market Share by Application (2019-2024)
11 Global Rofecoxib Market Segment by Type
11.1 Global Rofecoxib Revenue, Sales and Market Share by Type (2019-2024)
11.1.1 Global Rofecoxib Sales and Market Share by Type (2019-2024)
11.1.2 Global Rofecoxib Revenue and Market Share by Type (2019-2024)
11.2 Oral Suspension. Sales Growth Rate and Price
11.2.1 Global Oral Suspension. Sales Growth Rate (2019-2024)
11.2.2 Global Oral Suspension. Price (2019-2024)
11.3 Tablet-Form Sales Growth Rate and Price
11.3.1 Global Tablet-Form Sales Growth Rate (2019-2024)
11.3.2 Global Tablet-Form Price (2019-2024)
12 Global Rofecoxib Market Segment by Application
12.1 Global Rofecoxib Sales Market Share by Application (2019-2024)
12.2 Osteoarthritis Sales Growth Rate (2019-2024)
12.3 Rheumatoid Arthritis Sales Growth Rate (2019-2024)
12.4 Juvenile Rheumatoid Arthritis Sales Growth Rate (2019-2024)
12.5 Acute Pain Conditions Sales Growth Rate (2019-2024)
12.7 Dysmenorrhea Sales Growth Rate (2019-2024)
13 Global Rofecoxib Market Forecast
13.1 Global Rofecoxib Revenue, Sales and Growth Rate (2024-2029)
13.2 Rofecoxib Market Forecast by Regions (2024-2029)
13.2.1 North America Rofecoxib Market Forecast (2024-2029)
13.2.2 Europe Rofecoxib Market Forecast (2024-2029)
13.2.3 Asia-Pacific Rofecoxib Market Forecast (2024-2029)
13.2.4 South America Rofecoxib Market Forecast (2024-2029)
13.2.5 Middle East & Africa Rofecoxib Market Forecast (2024-2029)
13.3 Rofecoxib Market Forecast by Type (2024-2029)
13.3.1 Global Rofecoxib Sales Forecast by Type (2024-2029)
13.3.2 Global Rofecoxib Market Share Forecast by Type (2024-2029)
13.4 Rofecoxib Market Forecast by Application (2024-2029)
13.4.1 Global Rofecoxib Sales Forecast by Application (2024-2029)
13.4.2 Global Rofecoxib Market Share Forecast by Application (2024-2029)
14 Market Analysis
14.1.1 Market overview
14.1.2 Market Opportunities
14.1.3 Market Risk
14.1.4 Market Driving Force
14.1.5 Porter's Five Forces Analysis
14.1.6 SWOT Analysis
15 Rofecoxib Industry Related Market Analysis
15.1 Upstream Analysis
15.1.1 Macro Analysis of Upstream Markets
15.1.2 Key Players in Upstream Markets
15.1.3 Upstream Market Trend Analysis
15.1.4 Rofecoxib Manufacturing Cost Analysis
15.2 Downstream Market Analysis
15.2.1 Macro Analysis of Down Markets
15.2.2 Key Players in Down Markets
15.2.3 Downstream Market Trend Analysis
15.2.4 Sales Channel, Distributors, Traders and Dealers
List of Tables and Figures
Figure Product Picture Rofecoxib
Figure Market Concentration Ratio and Market Maturity Analysis of Rofecoxib
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Rofecoxib Market Size by Type
Figure Global Market Share of Rofecoxib by Type in 2023
Figure Oral Suspension. Picture
Figure Tablet-Form Picture
Table Global Rofecoxib Market Size (Volume) by Application
Figure Osteoarthritis Picture
Figure Rheumatoid Arthritis Picture
Figure Juvenile Rheumatoid Arthritis Picture
Figure Acute Pain Conditions Picture
Figure Migraine Picture
Figure Dysmenorrhea Picture
Table Global Rofecoxib Comparison by Regions (M USD) 2019-2029
Figure Global Rofecoxib Market Size (Million US$) (2019-2029)
Figure North America Rofecoxib Revenue (Million US$) Growth Rate (2019-2029)
Figure Europe Rofecoxib Revenue (Million US$) Growth Rate (2019-2029)
Figure Asia-pacific Rofecoxib Revenue (Million US$) Growth Rate (2019-2029)
Figure South America Rofecoxib Revenue (Million US$) Growth Rate (2019-2029)
Figure Middle East & Africa Rofecoxib Revenue (Million US$) Growth Rate (2019-2029)
Table Business Impact Assessment - Covid-19
Table Market Trends and Rofecoxib Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Rofecoxib Sales by Manufacturer (2019-2024)
Figure Global Rofecoxib Sales Market Share by Manufacturer in 2023
Table Global Rofecoxib Revenue by Manufacturer (2019-2024)
Figure Global Rofecoxib Revenue Market Share by Manufacturer in 2023
Table Global Rofecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Rofecoxib Manufacturer (Revenue) Market Share in 2023
Figure Top 10 Rofecoxib Manufacturer (Revenue) Market Share in 2023
Table Date of Key Manufacturers Enter into Rofecoxib Market
Table Key Manufacturers Rofecoxib Product Type
Table Mergers & Acquisitions Planning
Table Merck Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Merck
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Merck 2019-2024
Table Merck Main Business
Table Merck Recent Development
Table Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD 2019-2024
Table Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Main Business
Table Hubei TuoChu Kang Yuan Pharmaceutical Chemical Co. LTD Recent Development
Table Chengdu Meinkai Chemical Co. LTD Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Chengdu Meinkai Chemical Co. LTD
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Chengdu Meinkai Chemical Co. LTD 2019-2024
Table Chengdu Meinkai Chemical Co. LTD Main Business
Table Chengdu Meinkai Chemical Co. LTD Recent Development
Table Wuhan Xinxin Jiali Biotechnology Co. LTD Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Wuhan Xinxin Jiali Biotechnology Co. LTD
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Wuhan Xinxin Jiali Biotechnology Co. LTD 2019-2024
Table Wuhan Xinxin Jiali Biotechnology Co. LTD Main Business
Table Wuhan Xinxin Jiali Biotechnology Co. LTD Recent Development
Table Tremeau Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Tremeau
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Tremeau 2019-2024
Table Tremeau Main Business
Table Tremeau Recent Development
Table Pfizer Company Profile
Table Rofecoxib Product Introduction, Application and Specification of Pfizer
Table Rofecoxib Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Pfizer 2019-2024
Table Pfizer Main Business
Table Pfizer Recent Development
Figure Global Rofecoxib Sales and Growth Rate (2019-2024)
Figure Global Rofecoxib Revenue and Growth Rate (2019-2024)
Table Global Rofecoxib Sales by Regions (2019-2024)
Figure Global Rofecoxib Sales Market Share by Regions in 2023
Table Global Rofecoxib Revenue by Regions (2019-2024)
Figure Global Rofecoxib Revenue Market Share by Regions in 2023
Figure North America Rofecoxib Sales and Growth Rate (2019-2024)
Figure Europe Rofecoxib Sales and Growth Rate (2019-2024)
Figure Asia-pacific Rofecoxib Sales and Growth Rate (2019-2024)
Figure South America Rofecoxib Sales and Growth Rate (2019-2024)
Figure Middle East & Africa Rofecoxib Sales and Growth Rate (2019-2024)
Figure North America Rofecoxib Revenue and Growth Rate (2019-2024)
Table North America Rofecoxib Sales (Volume) by Countries (2019-2024)
Table North America Rofecoxib Sales Market Share by Countries (2019-2024)
Figure North America Rofecoxib Sales Market Share by Countries in 2023
Table North America Rofecoxib Revenue by Countries (2019-2024)
Table North America Rofecoxib Revenue Market Share by Countries (2019-2024)
Figure North America Rofecoxib Revenue Market Share by Countries in 2023
Figure United States Rofecoxib Sales and Growth Rate (2019-2024)
Figure Canada Rofecoxib Sales and Growth Rate (2019-2024)
Figure Mexico Rofecoxib Sales and Growth Rate (2019-2024)
Table North America Rofecoxib Revenue by Manufacturer (2023)
Figure North America Rofecoxib Revenue Market Share by Manufacturer in 2023
Table North America Rofecoxib Sales by Type (2019-2024)
Table North America Rofecoxib Sales Share by Type (2019-2024)
Table North America Rofecoxib Sales by Application (2019-2024)
Table North America Rofecoxib Sales Share by Application (2019-2024)
Figure Europe Rofecoxib Revenue and Growth Rate (2019-2024)
Table Europe Rofecoxib Sales (Volume) by Countries (2019-2024)
Table Europe Rofecoxib Sales Market Share by Countries (2019-2024)
Figure Europe Rofecoxib Sales Market Share by Countries in 2023
Table Europe Rofecoxib Revenue by Countries (2019-2024)
Table Europe Rofecoxib Revenue Market Share by Countries (2019-2024)
Figure Europe Rofecoxib Revenue Market Share by Countries in 2023
Figure Germany Rofecoxib Sales and Growth Rate (2019-2024)
Figure UK Rofecoxib Sales and Growth Rate (2019-2024)
Figure France Rofecoxib Sales and Growth Rate (2019-2024)
Figure Russia Rofecoxib Sales and Growth Rate (2019-2024)
Figure Italy Rofecoxib Sales and Growth Rate (2019-2024)
Figure Spain Rofecoxib Sales and Growth Rate (2019-2024)
Table Europe Rofecoxib Revenue by Manufacturer (2023)
Figure Europe Rofecoxib Revenue Market Share by Manufacturer in 2023
Table Europe Rofecoxib Sales by Type (2019-2024)
Table Europe Rofecoxib Sales Share by Type (2019-2024)
Table Europe Rofecoxib Sales by Application (2019-2024)
Table Europe Rofecoxib Sales Share by Application (2019-2024)
Figure Asia-pacific Rofecoxib Revenue and Growth Rate (2019-2024)
Table Asia-pacific Rofecoxib Sales (Volume) by Countries (2019-2024)
Table Asia-pacific Rofecoxib Sales Market Share by Countries (2019-2024)
Figure Asia-pacific Rofecoxib Sales Market Share by Countries in 2023
Table Asia-pacific Rofecoxib Revenue by Countries (2019-2024)
Table Asia-pacific Rofecoxib Revenue Market Share by Countries (2019-2024)
Figure Asia-pacific Rofecoxib Revenue Market Share by Countries in 2023
Figure China Rofecoxib Sales and Growth Rate (2019-2024)
Figure South Korea Rofecoxib Sales and Growth Rate (2019-2024)
Figure Japan Rofecoxib Sales and Growth Rate (2019-2024)
Figure Australia Rofecoxib Sales and Growth Rate (2019-2024)
Figure India Rofecoxib Sales and Growth Rate (2019-2024)
Figure Southeast Asia Rofecoxib Sales and Growth Rate (2019-2024)
Table Asia-pacific Rofecoxib Revenue by Manufacturer (2023)
Figure Asia-pacific Rofecoxib Revenue Market Share by Manufacturer in 2023
Table Asia-pacific Rofecoxib Sales by Type (2019-2024)
Table Asia-pacific Rofecoxib Sales Share by Type (2019-2024)
Table Asia-pacific Rofecoxib Sales by Application (2019-2024)
Table Asia-pacific Rofecoxib Sales Share by Application (2019-2024)
Figure South America Rofecoxib Revenue and Growth Rate (2019-2024)
Table South America Rofecoxib Sales (Volume) by Countries (2019-2024)
Table South America Rofecoxib Sales Market Share by Countries (2019-2024)
Figure South America Rofecoxib Sales Market Share by Countries in 2023
Table South America Rofecoxib Revenue by Countries (2019-2024)
Table South America Rofecoxib Revenue Market Share by Countries (2019-2024)
Figure South America Rofecoxib Revenue Market Share by Countries in 2023
Figure Brazil Rofecoxib Sales and Growth Rate (2019-2024)
Table South America Rofecoxib Sales by Type (2019-2024)
Table South America Rofecoxib Sales Share by Type (2019-2024)
Table South America Rofecoxib Revenue by Type (2019-2024)
Table South America Rofecoxib Revenue Share by Type (2019-2024)
Table South America Rofecoxib Sales by Application (2019-2024)
Table South America Rofecoxib Sales Share by Application (2019-2024)
Figure Middle East and Africa Rofecoxib Revenue and Growth Rate (2019-2024)
Table Middle East and Africa Rofecoxib Sales (Volume) by Countries (2019-2024)
Table Middle East and Africa Rofecoxib Sales Market Share by Countries (2019-2024)
Figure Middle East and Africa Rofecoxib Sales Market Share by Countries in 2023
Table Middle East and Africa Rofecoxib Revenue by Countries (2019-2024)
Table Middle East and Africa Rofecoxib Revenue Market Share by Countries (2019-2024)
Figure Middle East and Africa Rofecoxib Revenue Market Share by Countries in 2023
Figure GCC Countries Rofecoxib Sales and Growth Rate (2019-2024)
Figure Turkey Rofecoxib Sales and Growth Rate (2019-2024)
Figure Egypt Rofecoxib Sales and Growth Rate (2019-2024)
Figure South Africa Rofecoxib Sales and Growth Rate (2019-2024)
Table Middle East and Africa Rofecoxib Sales by Type (2019-2024)
Table Middle East and Africa Rofecoxib Sales Share by Type (2019-2024)
Table Middle East and Africa Rofecoxib Revenue by Type (2019-2024)
Table Middle East and Africa Rofecoxib Revenue Share by Type (2019-2024)
Table Middle East and Africa Rofecoxib Sales by Application (2019-2024)
Table Middle East and Africa Rofecoxib Sales Share by Application (2019-2024)
Table Global Rofecoxib Sales by Type (2019-2024)
Table Global Rofecoxib Sales Market Share by Type (2019-2024)
Figure Global Rofecoxib Sales Market Share by Type in 2023
Table Global Rofecoxib Revenue by Type (2019-2024)
Table Global Rofecoxib Revenue Market Share by Type (2019-2024)
Figure Global Rofecoxib Revenue Market Share by Type in 2023
Figure Global Oral Suspension. Sales Growth Rate (2019-2024)
Figure Global Oral Suspension. Price (2019-2024)
Figure Global Tablet-Form Sales Growth Rate (2019-2024)
Figure Global Tablet-Form Price (2019-2024)
Table Global Rofecoxib Sales by Application (2019-2024)
Table Global Rofecoxib Sales Market Share by Application (2019-2024)
Figure Global Rofecoxib Sales Market Share by Application in 2023
Figure Global Osteoarthritis Sales Growth Rate (2019-2024)
Figure Global Rheumatoid Arthritis Sales Growth Rate (2019-2024)
Figure Global Juvenile Rheumatoid Arthritis Sales Growth Rate (2019-2024)
Figure Global Acute Pain Conditions Sales Growth Rate (2019-2024)
Figure Global Migraine Sales Growth Rate (2019-2024)
Figure Global Dysmenorrhea Sales Growth Rate (2019-2024)
Figure Global Rofecoxib Sales and Growth Rate (2024-2029)
Figure Global Rofecoxib Revenue and Growth Rate (2024-2029)
Table Global Rofecoxib Sales Forecast by Regions (2024-2029)
Table Global Rofecoxib Market Share Forecast by Regions (2024-2029)
Figure North America Sales Rofecoxib Market Forecast (2024-2029)
Figure Europe Sales Rofecoxib Market Forecast (2024-2029)
Figure Asia-Pacific Sales Rofecoxib Market Forecast (2024-2029)
Figure South America Sales Rofecoxib Market Forecast (2024-2029)
Figure Middle East & Africa Sales Rofecoxib Market Forecast (2024-2029)
Table Global Rofecoxib Sales Forecast by Type (2024-2029)
Table Global Rofecoxib Market Share Forecast by Type (2024-2029)
Table Global Rofecoxib Sales Forecast by Application (2024-2029)
Table Global Rofecoxib Market Share Forecast by Application (2024-2029)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rofecoxib
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure Author List
Methodology/Research Approach
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.Research Programs/Design
| Historical Data (2015-2019) |
|
|
| Influencing Factors |
|
|
| Market Forecast (2021-2026) |
|
|
Market Size Estimation
Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).
The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.
Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report
The following figure shows an illustrative representation of the overall market size estimation process used for this study.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Data Source
Secondary Sources
Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.
Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
Key Executives Interviewed
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|